Filing search / Incannex Healthcare Limited / "Materials"

PRE 14A

IXHL Incannex Healthcare Limited

31 Oct 24

Preliminary proxy

4:10pm

Materials Soliciting Material Under §240.14a-12 Incannex Healthcare Inc. (Name of Registrant as Specified In Its Charter) (Name of Person(s … with preliminary materials Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 PRELIMINARY PROXY MATERIALS

8-K

EX-10.1

IXHL Incannex Healthcare Limited

24 Oct 24

Departure of Directors or Certain Officers

7:01am

, materials, memoranda, notes, records, reports or other documents or photocopies of the same. Employee may retain copies of any exclusively personal

10-K

2024 FY

IXHL Incannex Healthcare Limited

30 Sep 24

Annual report

7:30am

if the sponsor’s confirmatory trial fails to verify the claimed clinical benefits of the product. All promotional materials for drug candidates being … healthcare programs; and/or Mandated modification of promotional materials and labeling and the issuance of corrective information. In addition

8-K

EX-10.1

IXHL Incannex Healthcare Limited

10 Sep 24

Entry into a Material Definitive Agreement

7:30am

thereunder. “Exchange Cap” has the meaning set forth in the definition of “Commitment Amount”. “Hazardous Materials” shall have the meaning set forth … 501(a)(3) of Regulation D. Section 3.06 Information. The Investor and its advisors (and its counsel), if any, have been furnished with all materials

8-K

EX-10.2

IXHL Incannex Healthcare Limited

10 Sep 24

Entry into a Material Definitive Agreement

7:30am

or wastes (collectively, “Hazardous Materials”) into the environment, or otherwise relating to the manufacture, processing, distribution, use … , treatment, storage, disposal, transport or handling of Hazardous Materials, as well as all authorizations, codes, decrees, demands, or demand letters

S-1/A

btgu9zmjc2t

17 Jul 24

IPO registration (amended)

8:47am

S-1/A

EX-10.9

5fdt6pd79c ix

17 Jul 24

IPO registration (amended)

8:47am

S-1

196k0p3hp1

3 Jul 24

IPO registration

6:29am

8-K

EX-99.1

7b2qne r27mat7

17 Jan 24

Incannex Receives IRB Approval for the RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea

6:05am

6-K

EX-99.1

mt39un9q8qutajh6

10 Oct 23

Report of Foreign Private Issuer

6:15am

6-K

EX-99.2

g4jsxn7t2

5 Oct 23

Court Approves Convening of Meetings to Consider Proposed Schemes

7:47am

6-K

EX-99.1

abxt6ro

5 Oct 23

Court Approves Convening of Meetings to Consider Proposed Schemes

7:47am

6-K

EX-99.1

mdp7m t3go0k

1 Sep 23

Report of Foreign Private Issuer

8:43am

6-K

EX-99.1

qobglf2zqzpim1n1x 17

1 Sep 23

Report of Foreign Private Issuer

12:00am

20-F

9uhchshnhlktc56g0

28 Oct 22

Annual report (foreign)

6:31am

20-F

EX-2.3

weme4fah79

28 Oct 22

Annual report (foreign)

6:31am

6-K

EX-99.1

kbz842klx

19 Sep 22

Report of Foreign Private Issuer

9:38pm

6-K

EX-99.1

6p415u1d

9 Aug 22

Report of Foreign Private Issuer

6:01am

6-K

EX-99.3

ue35yeh6

12 May 22

Report of Foreign Private Issuer

9:25am